Bach Diagnostics
Bach Diagnostics is a 100% physician-owned clinical diagnostic laboratory operating CLIA-certified facilities in Irvine, CA and Westminster, CO, serving healthcare providers across the Western US with 304 tests spanning pathology, molecular diagnostics, clinical toxicology, ENFD testing, and routine laboratory services.
- Company typePrivate
- Founded-
- HeadquartersIrvine, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bach Diagnostics does
Bach Diagnostics is a 100% physician-owned clinical diagnostic laboratory headquartered in Irvine, California, with a second CLIA-certified facility in Westminster, Colorado. The company operates 304 diagnostic tests across six disciplines: anatomic pathology (dermatopathology, podiatric, and surgical), molecular infectious disease diagnostics via PCR, clinical toxicology using LC-MS/MS mass spectrometry, Epidermal Nerve Fiber Density (ENFD) testing for small fiber peripheral neuropathy, routine chemistry/hematology/coagulation/urinalysis, and histology/R&D/clinical trial services. Underlying technical infrastructure includes two HIPAA-compliant provider portals (LabNexus for toxicology and routine results; Lab Report Hub for molecular and pathology reports), custom HL7 integrations with 20+ named EMR/EHR platforms, same-day courier specimen pickup in Southern California, and a Square-powered patient billing portal. Federal CLIA certifications in California (05D2101629) and Colorado (06D2323945), plus a California CDPH Laboratory License (CLF-00348236), authorize the lab to bill Medicare, Medicaid, and commercial payers.
The company serves healthcare providers across physician offices, clinics, hospitals, urgent care centers, specialty clinics, nursing facilities, rehabilitation centers, pain management clinics, and mental health/behavioral health facilities, with a geographic focus on Southern California and the Western US. Leadership comprises board-certified pathologists with sub-specialty training from Johns Hopkins, UCLA, UC San Diego, UC Irvine, and Naval Hospital San Diego. Differentiated clinical performance metrics include ENFD testing with 90% sensitivity and 97% specificity, and a clinical toxicology menu covering 31 urine drug classes and 7 oral fluid drug classes (82 analytes) with next-day turnaround; most routine results are returned within 24-48 hours.
Bach Diagnostics generates revenue through transaction-based fee-for-service billing against contracted insurance reimbursement (in-network with 20+ carriers including Aetna, Blue Cross Blue Shield, Cigna, United Health Care, Medicare, Medi-Cal, Tricare, and multiple regional plans), direct billing to 15+ workers' compensation networks, and patient-pay arrangements including payment plans and financial assistance. Go-to-market is direct field sales to provider accounts, supported by a partnership request workflow, a client services team, and a targeted provider marketing presence via the company website and LinkedIn. The company is privately held with no disclosed funding rounds, revenue figures, or institutional investors, and operates with approximately 24 employees.
Bach Diagnostics firmographics
Firmographics- Name
- Bach Diagnostics
- Legal name
- Bach Diagnostics
- Website
- https://bachdx.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bach Diagnostics is a 100% physician-owned clinical diagnostic laboratory operating CLIA-certified facilities in Irvine, CA and Westminster, CO, serving healthcare providers across the Western US with 304 tests spanning pathology, molecular diagnostics, clinical toxicology, ENFD testing, and routine laboratory services.
- Ownership category
- akta.pro rank
Where Bach Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Bach Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Diagnostic Testing Services: Bach Diagnostics generates revenue through providing comprehensive diagnostic testing services including pathology, molecular diagnostics, clinical toxicology, and routine laboratory testing. Services are billed to insurance providers (in-network), workers' compensation plans, and patients directly. The company accepts major insurance carriers and offers payment plans and financial assistance for qualifying patients.
- Insurance Reimbursement: Revenue is collected through contracted insurance relationships with major carriers including Aetna, Blue Cross Blue Shield, Cigna, Health Net, Medicare, Medi-Cal, United Health Care, and Tricare. Workers' compensation billing is handled directly with workers' comp providers with generally no patient responsibility.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Insurance-based pricing for in-network carriers |
| Other | Pay-as-you-go | Supply materials provided at no additional cost |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Bach Diagnostics product offering
Product offeringCore offering
Bach Diagnostics is a 100% physician-owned clinical diagnostic laboratory operating CLIA-certified facilities in Irvine, California and Westminster, Colorado. The company provides comprehensive diagnostic testing services across pathology (dermatopathology, podiatric, surgical), molecular diagnostics (PCR-based infectious disease), clinical toxicology (LC-MS/MS), epidermal nerve fiber density (ENFD) testing, routine chemistry/hematology/coagulation/urinalysis, and histology/R&D/clinical trial services. Results are delivered through HIPAA-compliant portals (LabNexus and Lab Report Hub) and integrated into provider EMR/EHR systems via custom HL7 interfaces.
Product overview
Bach Diagnostics is a 100% physician-owned clinical laboratory offering a unified diagnostic testing platform across six core disciplines: Pathology (dermatopathology, podiatric, and surgical), Molecular Diagnostics (PCR-based infectious disease testing), Clinical Toxicology (LC/MS-based drug testing), Epidermal Nerve Fiber Density (ENFD) testing, Routine Testing (chemistry, hematology, coagulation, urinalysis), and Histology/R&D/Clinical Trials services. The portfolio encompasses 304 individual tests accessible via a complete test menu. Results are delivered through two HIPAA-compliant provider portals (LabNexus for toxicology/routine labs and Lab Report Hub for molecular/pathology), with EMR/EHR integration via custom HL7 interfaces supporting over 20 named EHR systems. The laboratory operates from CLIA-certified facilities in California (Irvine) and Colorado (Westminster).
Differentiator
Problem solved
Functional benefit
Products and services
- Pathology Services Comprehensive anatomic pathology services including dermatopathology, podiatric pathology, and surgical pathology with in-house histology, special stains, and immunohistochemistry for accurate diagnoses, supported by board-certified pathologists with 75+ years of combined experience.
- Dermatopathology Specialized skin biopsy evaluation by board-certified dermatopathologists covering pigmented lesions, inflammatory skin disorders, and benign and malignant cutaneous neoplasms, with high-resolution imagery and actionable treatment plans.
- Infectious Disease Testing (Molecular Diagnostics) PCR-based molecular diagnostics panels covering fungal, wound, UTI, women's health, and respiratory pathogens with 24-72 hour turnaround and antibiotic treatment recommendations based on current guidelines.
- Clinical Toxicology Clinical toxicology testing with presumptive screening and definitive confirmation using liquid chromatography-mass spectrometry (LC-MS/MS), covering 31 drug classes for urine and 7 for oral fluid testing (82 total analytes) with next-day turnaround.
- Epidermal Nerve Fiber Density (ENFD) Testing Quantitative skin biopsy analysis for objective diagnosis of small fiber peripheral neuropathy using PGP 9.5 immunohistochemical staining, with up to 90% sensitivity and 97% specificity.
- Routine Testing Routine laboratory testing including clinical chemistry (CMP, lipid panels, thyroid panels), hematology (CBC), coagulation (PT, APTT, INR), and urinalysis with same-day processing and 24-hour turnaround.
- Histology, R&D, and Clinical Trials Services Professional histology services including custom immunohistochemical staining, routine grossing and staining, R&D testing, clinical validations, and bio-repository services for clinical trials.
- LabNexus Portal HIPAA-compliant secure online portal for healthcare providers to access toxicology panels, routine chemistry, hematology, and general laboratory test results 24/7.
- Lab Report Hub HIPAA-compliant secure online portal for accessing molecular diagnostics, pathology reports, and specialized testing results.
- Complete Test Menu (304 Tests) Comprehensive menu of 304 laboratory tests across pathology, molecular diagnostics, clinical toxicology, urinalysis, chemistry, and hematology categories with specimen collection container options and turnaround times.
Quantifiable outcome
- 90% sensitivity and 97% specificity for ENFD testing
- +2 more outcomes
Companies that use Bach Diagnostics
Customer profileSegments3 records
Ideal customer profiles2 records
Bach Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration25 records
Feature4 records
Bach Diagnostics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- EMR/EHR Integration PartnerscoreBach Diagnostics offers integration with leading EMR and EHR systems to streamline ordering and result delivery. Custom HL7 interfaces enable direct integration into existing provider workflows. Integrated systems include Advanced MD, athenaOne, Azalea, Charm, Dr. Chrono, eClinicalWorks, Elation, Experity, Kipu Health, MatrixCare, MedConnect, Modernizing Medicine (EMA), myUnity (Netsmart), NextGen Office (HealthFusion), Office Ally, PointClickCare, Practice Fusion, PrognoCIS, RXNT, SigmaCare, Tebra (formerly Kareo), and Waiting Room Solutions.
- Major Insurance CarrierscoreBach Diagnostics is contracted as an in-network laboratory with major insurance providers including Aetna, AHCCCS, Blue Shield, Blue Cross, Cigna, CorVel, Health Net, Medicare, Medi-Cal, Molina of Ohio, MultiPlan, Novitas Colorado Medi-Care, Ohio Medicaid, Palmetto, Railroad Medi-Care, PRIME Health Networks, Three Rivers Networks, TriCare, TriWest Veterans Affairs, and United Health Care.
- Workers' Compensation NetworkscoreBach Diagnostics is contracted with workers' compensation providers including AICS, F.A. Richard, Fireman's Fund, Gallagher Bassett, Genex Services, HCA Account Plan, Hortica, Magna Carta, Matrix, MediCore, Sedgwick, Sentry, SRS Account Plan, SUA, Tokio Marine, Tri-Star, and Zurich for direct billing of workers' compensation cases.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Bach Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: National clinical reference laboratory offering routine, esoteric, molecular, and pathology testing. Overlaps with Bach on routine chemistry, molecular infectious disease, toxicology, and anatomic pathology, but operates at vastly larger scale with national infrastructure.
- Sonic Healthcare USA: Subsidiary of Sonic Healthcare providing anatomic and clinical pathology services across multiple US regions. Comparable specialty pathology focus, multi-state operating model, and physician-client services approach.
- Laboratory Corporation of America (LabCorp): Largest US clinical laboratory network providing routine, specialty, molecular and anatomic pathology services. Directly comparable on test menu breadth and physician-office service model, but with a national footprint that dwarfs Bach's regional presence.
Direct peers
- PathGroup: Physician-led anatomic and molecular pathology laboratory with broad subspecialty expertise across dermatopathology, GI, and podiatric pathology. Closest peer on physician-owned specialty pathology model and provider-channel GTM.
- ARUP Laboratories: Nonprofit academic clinical reference laboratory offering esoteric and routine testing, with strong specialty pathology and consultative physician support. Highly comparable as a physician-led, specialty-rich lab serving healthcare providers rather than direct-to-consumer.
- BioReference Laboratories: Specialty clinical laboratory (now part of OPKO Health) focused on esoteric testing, molecular diagnostics, women's health and oncology. Comparable breadth of specialty testing and physician-channel positioning to Bach.
- NeoGenomics: Specialty oncology and molecular diagnostics laboratory serving hospitals, oncologists and pathology practices. Comparable as a specialty-driven, high-complexity clinical lab with physician-office customer base.
- Inform Diagnostics: Specialty pathology laboratory with strong dermatopathology and GI pathology expertise serving physician practices. Closely comparable on physician-channel dermatopathology and anatomic pathology services.
Emerging players
- Acutis Diagnostics: Mid-sized specialty clinical laboratory focused on molecular diagnostics, infectious disease, and toxicology testing with physician-office client base. Highly comparable on specialty molecular/toxicology menu and provider GTM, though smaller scale.
Regional players
- CompuNet Clinical Laboratories: Regional reference laboratory serving the Western US with routine and specialty testing for healthcare providers. Comparable on clinical test menu, regional footprint, and physician-office service model, though slightly different geographic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bach Diagnostics social profiles
Digital presenceBach Diagnostics compliance and trust
Trust signalCompliance3 records
Bach Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bach Diagnostics leadership team
Management profileNumber of profiles
Profiles4 records
Bach Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bach Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bach Diagnostics
What does Bach Diagnostics do?
Bach Diagnostics is a 100% physician-owned clinical diagnostic laboratory operating CLIA-certified facilities in Irvine, California and Westminster, Colorado. The company provides comprehensive diagnostic testing services across pathology (dermatopathology, podiatric, surgical), molecular diagnostics (PCR-based infectious disease), clinical toxicology (LC-MS/MS), epidermal nerve fiber density (ENFD) testing, routine chemistry/hematology/coagulation/urinalysis, and histology/R&D/clinical trial services. Results are delivered through HIPAA-compliant portals (LabNexus and Lab Report Hub) and integrated into provider EMR/EHR systems via custom HL7 interfaces.
Is Bach Diagnostics a public or private company?
Bach Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bach Diagnostics founded?
Bach Diagnostics was founded in -1. It employs 11 to 50 people.
Where is Bach Diagnostics based?
Bach Diagnostics is headquartered in Irvine, United States, in the North America region.
How does Bach Diagnostics make money?
Two revenue lines are on record. Laboratory Diagnostic Testing Services are the primary driver. The others are insurance Reimbursement.
Who are Bach Diagnostics's main competitors?
Broad incumbents on record are Quest Diagnostics, Sonic Healthcare USA and Laboratory Corporation of America (LabCorp). Direct peers are PathGroup, ARUP Laboratories, BioReference Laboratories, NeoGenomics and Inform Diagnostics. Acutis Diagnostics is listed as an emerging player. CompuNet Clinical Laboratories is listed as a regional player.
Does Bach Diagnostics have an API?
No public API is recorded for Bach Diagnostics.